A

American Research Institute | Cutler Bay, FL

Research site

(Unclaimed)

Location

18951 SW 106th Ave, Suite B-110, Cutler Bay, Florida, United States of America

Site insights

Top conditions

Top treatments

Ozanimod

Relamorelin

Lanifibranor

Linaprazan Glurate

Retatrutide

fezolinetant

Methotrexate

Lansoprazole

TVB-2640

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 13 total trials

A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3

Enrolling

NASH - Nonalcoholic Steatohepatitis

Drug: Placebo

Drug: IVA337

A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Participants With Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD)

The goal of this clinical trial is to find out how well linaprazan glurate can heal erosive esophagitis (EE) caused by gastroesophageal reflux diseas...

Begins enrollment in 1 month

GERD (Gastroesophageal Reflux Disease)

Drug: Linaprazan glurate 50 mg Twice Daily (BID)

Drug: Lansoprazole 30 mg Once Daily (QD)

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent...

Enrolling

Atherosclerotic Cardiovascular Disease (ASCVD)

Chronic Kidney Disease (CKD)

Drug: Retatrutide

Drug: Placebo